Archives

by in
Entry Author Date Location
Alnylam Eyes RNAi for Manufacturing Drugs 11/12/09 Boston
Synageva Finishes $45M Round 10/20/09 Boston
New England Firms Poised for Biogeneric Future, Tobin Bids Boston Scientific Adieu, Biogen Idec Reports Tenth PML Case, & More Boston-Area Life Sciences News 07/01/09 Boston
Biogen and Fellow Boston-Area Biotechs Ready for Biogenerics 06/24/09 Boston
FDA Decision a Blow For Genzyme—and Biogenerics? 04/22/08 Boston
GTC Biotherapeutics, Racing Against Time to Prove the Worth of “Pharming” 02/11/08 Boston
Setback for Momenta, Setback for Biogenerics? 11/08/07 Boston
The State of Biotechnology, According to Biogen Idec CEO Jim Mullen 08/16/07 Boston
Genzyme’s Myozyme Production Problems Fuel Online Biogenerics Debate 08/10/07 Boston
Page 1 of 1